Checked Sep 25, 2026Start a new check

What was checked

New study reports Fenbendazole linked to remission or near-remission in THREE Stage IV Cancer Patients (breast, prostate, melanoma) with dramatic tumor regression and long-lasting remission without chemotherapy. Clinical trials should be urgently initiated.

Assessment summary

Needs caution

The case series reported sustained outcomes and no chemotherapy, but patients received other treatments such as hormone therapy, radiation, surgery, supplements, or androgen-deprivation therapy. These uncontrolled cases cannot show that fenbendazole caused tumor regression or remission. This is a recommendation rather than a directly testable fact. Fenbendazole may warrant properly designed research, but available sources do not establish an urgent clinical need or demonstrated effectiveness in humans; experts report insufficient evidence of safety and efficacy. (Only 1 of 3 AI systems responded.)

This saved result keeps its original verdict. Our current method would assess it differently, so grouped findings are not shown here. Review the model assessments below or start a new check for an updated report.

Model assessments

Assessment summary

The case series did report three stage IV patients with breast, prostate, and melanoma cancers who experienced complete or near-complete remission while using fenbendazole with other treatments.pmc.ncbi.nlm.nih.gov However, the paper was later listed as retracted, and the cases cannot establish that fenbendazole caused the outcomes.karger.com Reliable medical sources state that human evidence is insufficient and no clinical trials have proven fenbendazole effective against cancer.cancer.org cancerexplained.org

Claims reviewed

The patients had dramatic tumor regression and long-lasting remission without chemotherapy.

Needs context
The case series reported sustained outcomes and no chemotherapy, but patients received other treatments such as hormone therapy, radiation, surgery, supplements, or androgen-deprivation therapy.pmc.ncbi.nlm.nih.gov These uncontrolled cases cannot show that fenbendazole caused tumor regression or remission.

This claim may mislead readers without added context.

Clinical trials should be urgently initiated.

Can’t verify
This is a recommendation rather than a directly testable fact. Fenbendazole may warrant properly designed research, but available sources do not establish an urgent clinical need or demonstrated effectiveness in humans; experts report insufficient evidence of safety and efficacy.cancer.org cancerexplained.org

A study reported three stage IV cancer patients with breast, prostate, and melanoma cancers who achieved remission or near-remission while taking fenbendazole.

Supported
A 2025 case series described three such patients and reported two complete remissions and one near-complete remission.pmc.ncbi.nlm.nih.gov The report was subsequently identified as retracted, which substantially limits its evidentiary value.karger.com
ClaudeDid not respond
ChatGPTDid not respond

Sources cited

15 sources

Share this result